Westbourne Investment Advisors Inc. Acquires Shares of DocuSign, Inc. (NASDAQ:DOCU)

Financial Advisors


Westbourne Investment Advisors increased its stake in DocuSign (NASDAQ:DOCU – Get Rating) by 11.2% in the fourth quarter, according to the company’s latest filing with the Securities and Exchange Commission. . The institutional investor held 30,960 shares in the company after purchasing another 3,106 shares during the quarter. Westbourne Investment Advisors’ DocuSign holding was valued at $1,716,000 at the time of the latest SEC filing.

Several other hedge funds have also changed their stakes. MetLife Investment Management LLC acquired new shares of his DocuSign stock worth approximately $1,337,000 during the first quarter. Raymond James Trust NA increased his stake in DocuSign by 27.3% in the first quarter. Raymond James Trust, NA purchased an additional 901 shares during the last quarter and now owns 4,206 shares of the company, valued at $450,000. Sei Investments Co. increased its stake in DocuSign by 21.8% in the first quarter. Sei Investments Co. acquired an additional 31,769 shares during the period and now owns 177,214 shares of the company worth $18,934,000. The National Pension Corporation expanded its position in DocuSign shares by 25.9% in the first quarter. The National Pension Service acquired an additional 71,449 shares last quarter and now holds 347,633 shares in the company, valued at $37,238,000. Finally, Vanguard Group Inc. increased his DocuSign stake by 20.3% in the first quarter. Vanguard Group Inc. acquired an additional 2,917,683 shares during the period and now owns 17,308,877 shares of the company stock valued at $1,854,127,000. Institutional investors and hedge funds currently hold 76.18% of the shares.

DocuSign Insider Trading

In other news, director Teresa Briggs sold 1,988 shares of the company in a transaction on Thursday, March 16. The shares sold at an average price of $58.53 for a total transaction value of $116,357.64. After the sale, the directors now own 3,763 shares of the company, valued at $220,248.39. The transaction was disclosed in legal filings with the Securities and Exchange Commission, which are available on the SEC’s website. Currently, 2.55% of the shares are owned by insiders.

DocuSign deals down 1.2%

Nasdaq: DOCU shares fell $0.60 to $50.50 in Tuesday midday trading. Average turnover was 486,607 shares traded against his 3,921,063 shares. The stock has a market cap of $10.22 billion, a P/E of -104.29, a PEG ratio of 14.18 and a beta of 0.98. The company has a 50-day moving average price of $54.22 and a 200-day moving average price of $54.48. DocuSign shares are at a 12-month low of $39.57 and a high of $92.04.

DocuSign (NASDAQ:DOCU – Get Rating) last released its quarterly earnings data on Thursday, March 9. The company reported earnings per share (EPS) of $0.07 for the quarter, beating consensus expectations of $0.04 by $0.03. The business reported revenue of $659.58 million for the quarter, compared to consensus expectations of $639.39 million. DocuSign had a return on equity of 7.15% and a negative net profit margin of 3.87%. On average, equity research analysts expect him to earn 0.24 per share for DocuSign this year.

Analysts set new price target

A number of research analysts have commented on the DOCU stock. UBS Group downgraded DocuSign shares from ‘neutral’ to ‘sell’ and set a price target of $52.00. In a research note on Tuesday, February 21. Robert W. Baird raised DocuSign’s price target from $50.00 to $70.00 in a research note on Friday, March 10. Wedbush raised its price target on DocuSign from $55.00 to $60.00, giving the company a “neutral” rating in a research note on Friday, March 10. Royal Bank of Canada raised its price target on DocuSign from $53.00 to $59.00 and rated the stock as ‘Sector Performing’ in a research note on Friday, March 10. Finally, Wolfe Research upgraded DocuSign’s stock from ‘underperforming’ to ‘peer performing’ in its research report on Thursday, February 23rd. Three analysts rated the stock as “sell”, nine “hold” and three “buy”. The company currently has a consensus rating of “Hold” and an average target price of $62.93, according to MarketBeat.com data.

About DocuSign

(get rating)

DocuSign, Inc provides a cloud-based electronic signature solution. A cloud-based e-signature platform helps businesses and individuals securely collect information, automate data workflows, and sign anything. The company automates manual, paper-based processes and enables users to manage all aspects of documented business transactions, including identity management, authentication, digital signatures, forms and data collection, collaboration, workflow automation and storage. to

Featured article

DocuSign Institutional Ownership Quarterly (NASDAQ:DOCU)

This instant news alert was generated by MarketBeat’s narrative science technology and financial data to provide our readers with the fastest and most accurate reporting. This article was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments regarding this story to contact@marketbeat.com.

Listen to this before you consider DocuSign.

MarketBeat tracks Wall Street’s highest-rated, highest-performing research analysts and the stocks they recommend to clients every day. MarketBeat identified five stocks top analysts are quietly whispering to customers to buy now before the whole market goes up, but DocuSign was not on the list.

DocuSign currently has a Hold rating among analysts, but high-scoring analysts think these five stocks are better buys.

Click here for 5 brands

5G Stocks: The Road Ahead Is Profitable Cover



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *